Non-invasive Detection of Coronary Artery Stenosis
NIDCAS
1 other identifier
observational
20
1 country
1
Brief Summary
The aim of this viability study is to investigate using a novel medical device, the potential for detecting partial blockages in the arteries within the wall of the heart (coronary artery stenosis). A prototype device will be used in the proposed study. It is a stick-on patch containing sensors which measure the vibration produced at the chest surface by flowing blood as it accelerates through the narrowed artery in the heart emerging downstream, hitting the inner wall of the artery and causing it to vibrate. Some of the energy in the vibrations reaches the skin of the chest, allowing the blockage to be detected non-invasively. The principle has been proved in the laboratory using a simple chest model but to date no measurements have been made in people. Therefore, the proposed trial will serve as the first in-human measurements and will involve a small number of patients and healthy volunteers, with the objective of establishing if it is possible to determine the presence or absence of the stenosis. The patch will be tested by recording acoustic signatures in healthy volunteers, then in patients undergoing coronary CT angiography. Results will be validated against the CT angiography gold standard. At this early stage no clinical decisions will be made based on the patch recordings and the data will be used only to assess the feasibility of continuing the development of the device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2024
CompletedFirst Posted
Study publicly available on registry
December 27, 2024
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedDecember 27, 2024
December 1, 2024
5 months
December 17, 2024
December 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy
Diagnostic accuracy of the device (stick-on patch) for indicating the presence or absence of one or more coronary arterial stenoses as indicated by the reference method (angiography/CT angiography results). This will be expressed as: Np/(Na+Np) x100. Where: Np is the number of positive diagnoses of coronary artery disease derived from the patch measurements Na is the number of positive diagnoses of coronary artery disease (with at least one lesion showing a reduction in maximum stenosis lumen diameter 0.8 of more) derived from the angiography images. This is a dimensionless quantity
Immediately following patch recording and imaging
Secondary Outcomes (3)
Stenosis severity
Immediately following the patch recordings and imaging
Patch wearability
Immediately following the patch recordings and imaging
Ease of patch removal
Immediately following the patch recordings and imaging
Study Arms (2)
Coronary Artery Disease (CAD)
Patients in whom occlusive coronary artery disease has been diagnosed by angiography or CT angiography
Control
Healthy volunteers and/or patients in whom no CAD has been identified on angiography or CT angiography
Eligibility Criteria
Approximately equal numbers of symptomatic and asymptomatic subjects undergoing angiography or CT angiography at the Cleveland Clinic, London, UK
You may qualify if:
- Patient is able to provide written informed consent
- Age ≥18 years;
- Investigation for suspected stable coronary artery disease/stenosis isolated from other cardiac comorbidities.
- Subjects of either sex. Female subjects of child-bearing potential will be included if deemed suitable for clinically mandated coronary CTa.
- No infectious disease or neoplasia.
You may not qualify if:
- Indications to coronary CTa different from isolated suspected stable coronary artery disease, such as acute coronary syndrome, unstable angina, congenital heart disease, cardiomyopathy, heart valve disease, aortic coarctation, electrophysiological disorder/arrhythmia, screening study, unstable clinical condition, left ventricular ejection fraction \<35%, previous coronary revascularization (PCI or CABG surgery), previous heart valve surgery or transcatheter valve replacement, pace maker or implantable defibrillator.
- If female and of child-bearing potential: evidence of a positive pregnancy test or a stated intention to become pregnant in the next 6-12 months;
- Currently participating in another device or drug study or has done so in previous 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nilocaslead
- Queen Mary University of Londoncollaborator
Study Sites (1)
Cleveland Clinic Portland Place Outpatient Centre 24 Portland Place
London, W1B 1LU, United Kingdom
Related Publications (4)
Banks HT, Hu S, Kenz ZR, Kruse C, Shaw S, Whiteman J, Brewin MP, Greenwald SE, Birch MJ. Model validation for a noninvasive arterial stenosis detection problem. Math Biosci Eng. 2014 Jun;11(3):427-48. doi: 10.3934/mbe.2014.11.427.
PMID: 24506547BACKGROUNDBrewin MP, Birch MJ, Mehta DJ, Reeves JW, Shaw S, Kruse C, Whiteman JR, Hu S, Kenz ZR, Banks HT, Greenwald SE. Characterisation of Elastic and Acoustic Properties of an Agar-Based Tissue Mimicking Material. Ann Biomed Eng. 2015 Oct;43(10):2587-96. doi: 10.1007/s10439-015-1294-7. Epub 2015 Mar 14.
PMID: 25773982BACKGROUNDSangster JF, Oakley CM. Diastolic murmur of coronary artery stenosis. Br Heart J. 1973 Aug;35(8):840-4. doi: 10.1136/hrt.35.8.840. No abstract available.
PMID: 4542336BACKGROUNDSemmlow J, Rahalkar K. Acoustic detection of coronary artery disease. Annu Rev Biomed Eng. 2007;9:449-69. doi: 10.1146/annurev.bioeng.9.060906.151840.
PMID: 17425468BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francesca Pugliese, MD
Queen Mary University of London
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Cardiovascular Mechanics
Study Record Dates
First Submitted
December 17, 2024
First Posted
December 27, 2024
Study Start
May 1, 2025
Primary Completion
October 1, 2025
Study Completion
December 1, 2025
Last Updated
December 27, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
The results of this preliminary viability study will be described in an internal report and this will be used to provided evidence when seeking funding for a larger validation trial. They will not therefore be published.